國立虎尾科技大學 |

Advances in Diagnosis and Management of Cutaneous Adverse Drug Reactions = Current and Future Trends /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Advances in Diagnosis and Management of Cutaneous Adverse Drug Reactions/ edited by Neil H. Shear, Roni P. Dodiuk-Gad.
Reminder of title:	Current and Future Trends /
other author:	Shear, Neil H.
Description:	XII, 314 p. 95 illus., 91 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Pharmacy. -
Online resource:	https://doi.org/10.1007/978-981-13-1489-6
ISBN:	9789811314896

Advances in Diagnosis and Management of Cutaneous Adverse Drug Reactions = Current and Future Trends /
Advances in Diagnosis and Management of Cutaneous Adverse Drug ReactionsCurrent and Future Trends /[electronic resource] :edited by Neil H. Shear, Roni P. Dodiuk-Gad. - 1st ed. 2019. - XII, 314 p. 95 illus., 91 illus. in color.online resource.

Section I. Introduction -- 1. Introduction: Classification, Terminology, Epidemiology and Etiology of Cutaneous Adverse Drug Reactions -- Section II. Pathomechanisms of Cutaneous Adverse Drug Reactions -- 2. Immunology of Cutaneous Adverse Drug Reactions -- 3. Pharmacogenomics and Cutaneous Adverse Drug Reactions -- 4 Viral Reactivation in Cutaneous Adverse Drug Reactions -- 5. Using Technology to Learn About Immunology of Cutaneous Adverse Drug Reactions -- Section III. Clinical Perspectives of Cutaneous Adverse Drug Reactions -- 6. Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (Epithelial Necrolysis) -- 7. Drug Reaction with Eosinophilia and Systemic Symptoms -- 8. Acute Generalized Exanthematous Pustulosis -- 9. Urticarial Reactions to Drugs -- 10. Dermatological Adverse Events from Cancer Treatments -- 11. Cutaneous Adverse Drug Reactions in Pediatric Population -- 12. Cutaneous Drug Reactions in the Elderly -- 13. Cutaneous Adverse Drug Reactions in Human Immunodeficiency Virus Patients -- 14. Cutaneous Adverse Drug Reactions from Anti-Tuberculosis Treatment -- Section IV. Approach to the Patient with a Cutaneous Adverse Drug Reaction -- 15. Practical Approach to Diagnosis and Management of Cutaneous Adverse Drug Reactions -- 16. Histopathology of Severe Drug Eruptions -- 17. Evaluation of Drug Safety Literature: A Guide for the Practicing Dermatologist -- 18. In vitro and in vivo tests in Cutaneous Adverse Drug Reactions -- 19. Pharmacovigilance of Cutaneous Adverse Drug Reactions -- Section V. Epilogue -- 20. Future Directions and Unmet Research Needs in Cutaneous Adverse Drug Reactions -- 21. Atlas of Cutaneous Adverse Drug Reactions.

This resource guides prescribers, pharmacists, and regulators with an update on the recent expansion of basic and clinical knowledge that forms a framework for understanding cutaneous reactions. This understanding will lead, in turn, to better outcomes and decisions in treatment and management, both in the clinic and in the life cycle of drug development. The skin is a common target for adverse drug events and even mild rashes can be part of life-threatening syndromes. Patients and practitioners often face important decisions about therapy after a drug eruption, including treatment, cross-reactivity with future pharmaceuticals, genetic considerations and dealing with long-term sequelae after a reaction. An international team of experts and leaders in the field share their story and insights into the scientific details and relevant clinical context.

ISBN: 9789811314896

Standard No.: 10.1007/978-981-13-1489-6doiSubjects--Topical Terms:

582411
Pharmacy.

LC Class. No.: RS1-441

Dewey Class. No.: 353.998

Advances in Diagnosis and Management of Cutaneous Adverse Drug Reactions = Current and Future Trends /
LDR:03920nam a22003975i 4500 001 1006196
003 DE-He213
005 20200706142901.0
007 cr nn 008mamaa
008 210106s2019 si | s |||| 0|eng d
020 $a 9789811314896 $9 978-981-13-1489-6
024 7 $a 10.1007/978-981-13-1489-6 $2 doi
035 $a 978-981-13-1489-6
050 4 $a RS1-441
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
072 7 $a MKG $2 thema
082 0 4 $a 353.998 $2 23
245 1 0 $a Advances in Diagnosis and Management of Cutaneous Adverse Drug Reactions $h [electronic resource] : $b Current and Future Trends / $c edited by Neil H. Shear, Roni P. Dodiuk-Gad.
250 $a 1st ed. 2019.
264 1 $a Singapore : $b Springer Singapore : $b Imprint: Adis, $c 2019.
300 $a XII, 314 p. 95 illus., 91 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Section I. Introduction -- 1. Introduction: Classification, Terminology, Epidemiology and Etiology of Cutaneous Adverse Drug Reactions -- Section II. Pathomechanisms of Cutaneous Adverse Drug Reactions -- 2. Immunology of Cutaneous Adverse Drug Reactions -- 3. Pharmacogenomics and Cutaneous Adverse Drug Reactions -- 4 Viral Reactivation in Cutaneous Adverse Drug Reactions -- 5. Using Technology to Learn About Immunology of Cutaneous Adverse Drug Reactions -- Section III. Clinical Perspectives of Cutaneous Adverse Drug Reactions -- 6. Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (Epithelial Necrolysis) -- 7. Drug Reaction with Eosinophilia and Systemic Symptoms -- 8. Acute Generalized Exanthematous Pustulosis -- 9. Urticarial Reactions to Drugs -- 10. Dermatological Adverse Events from Cancer Treatments -- 11. Cutaneous Adverse Drug Reactions in Pediatric Population -- 12. Cutaneous Drug Reactions in the Elderly -- 13. Cutaneous Adverse Drug Reactions in Human Immunodeficiency Virus Patients -- 14. Cutaneous Adverse Drug Reactions from Anti-Tuberculosis Treatment -- Section IV. Approach to the Patient with a Cutaneous Adverse Drug Reaction -- 15. Practical Approach to Diagnosis and Management of Cutaneous Adverse Drug Reactions -- 16. Histopathology of Severe Drug Eruptions -- 17. Evaluation of Drug Safety Literature: A Guide for the Practicing Dermatologist -- 18. In vitro and in vivo tests in Cutaneous Adverse Drug Reactions -- 19. Pharmacovigilance of Cutaneous Adverse Drug Reactions -- Section V. Epilogue -- 20. Future Directions and Unmet Research Needs in Cutaneous Adverse Drug Reactions -- 21. Atlas of Cutaneous Adverse Drug Reactions.
520 $a This resource guides prescribers, pharmacists, and regulators with an update on the recent expansion of basic and clinical knowledge that forms a framework for understanding cutaneous reactions. This understanding will lead, in turn, to better outcomes and decisions in treatment and management, both in the clinic and in the life cycle of drug development. The skin is a common target for adverse drug events and even mild rashes can be part of life-threatening syndromes. Patients and practitioners often face important decisions about therapy after a drug eruption, including treatment, cross-reactivity with future pharmaceuticals, genetic considerations and dealing with long-term sequelae after a reaction. An international team of experts and leaders in the field share their story and insights into the scientific details and relevant clinical context.
650 0 $a Pharmacy. $3 582411
650 0 $a Pharmacology. $3 583819
650 1 4 $a Drug Safety and Pharmacovigilance. $3 1064651
650 2 4 $a Pharmacology/Toxicology. $3 593882
700 1 $a Shear, Neil H. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1299693
700 1 $a Dodiuk-Gad, Roni P. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1299694
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9789811314889
776 0 8 $i Printed edition: $z 9789811314902
776 0 8 $i Printed edition: $z 9789811346415
856 4 0 $u https://doi.org/10.1007/978-981-13-1489-6
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)